Skip to main content

Gen-Probe, Tosoh Bioscience Cross-License Nucleic Acid Testing IP

NEW YORK, Dec. 9 - Gen-Probe and the Tosoh Bioscience unit of Tokyo-based Tosoh Corp. said today that they have cross-licensed intellectual property covering certain nucleic acid testing technologies.

Tosoh will receive non-exclusive rights to Gen-Probe's transcription-mediated amplification (TMA) and ribosomal RNA technologies in exchange for two payments in 2004. Tosoh will also pay Gen-Probe royalties on worldwide sales of products based on the licensed Gen-Probe technologies.
Gen-Probe will gain access, in exchange for royalties, to Tosoh's patented TRC (t
ranscription reverse-transcription concerted) amplification and INAF (intercalation activating fluorescence) detection technologies for use with real-time TMA.

The licenses are effective Jan. 1, 2004.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.